Glycan modification of glioblastoma-derived extracellular vesicles enhances receptor-mediated targeting of dendritic cells
/in Dendritic Cells, Exosome, Glioblastoma, International Publications /von 2019-08-09 / J Extracell Vesicles 2019;8(1):1648995A Phase Ib Study of the Combination of Personalized Autologous Dendritic Cell Vaccine, Aspirin, and Standard of Care Adjuvant Chemotherapy Followed by Nivolumab for Resected Pancreatic Adenocarcinoma-A Proof of Antigen Discovery Feasibility in Three Patients
/in Dendritic Cells, International Publications, Pancreatic Cancer /von 2019-08-08 / Front Immunol 2019;10:1832Honokiol-enhanced cytotoxic T lymphocyte activity against cholangiocarcinoma cells mediated by dendritic cells pulsed with damage-associated molecular patterns
/in Dendritic Cells, Gallbladder Cancer, International Publications /von 2019-08-07 / World J Gastroenterol 2019 Aug;25(29):3941-3955Immunotherapy with dendritic cells and cytokine-induced killer cells for hepatocellular carcinoma: A meta-analysis
/in Dendritic Cells, Hepatocellular Carcinoma, International Publications /von 2019-07-21 / World J. Gastroenterol. 2019 Jul;25(27):3649-3663Trial watch: dendritic cell vaccination for cancer immunotherapy
/in Dendritic Cells, International Publications /von 2019-07-18 / Oncoimmunology 2019;8(11):e1638212Hepatocellular carcinoma: Mechanisms of progression and immunotherapy
/in Dendritic Cells, Hepatocellular Carcinoma, International Publications /von 2019-07-07 / World J. Gastroenterol. 2019 Jul;25(25):3151-3167Immunotherapy for hepatocellular carcinoma: Current and future
/in Dendritic Cells, Hepatocellular Carcinoma, International Publications /von 2019-06-28 / World J. Gastroenterol. 2019 Jun;25(24):2977-2989Can Dendritic Cell Vaccination Prevent Leukemia Relapse?
/in Acute Leukemia, Dendritic Cells, International Publications /von 2019-06-22 / Cancers (Basel) 2019 Jun;11(6)Dendritic cell/cytokine-induced killer cell-based immunotherapy in lung cancer: What we know and future landscape
/in Dendritic Cells, International Publications, NSCLC /von 2019-06-21 / J. Cell. Physiol. 2020 Jan;235(1):74-86IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de